Characterization of Antisense Oligonucleotides Comprising 2'-Deoxy-2'-Fluoro-beta-D-Arabinonucleic Acid (FANA): Specificity, Potency, and Duration of Activity

Autor:	Masad J. Damha, Denis Bergeron, Luc Paquet, Paolo M. Renzi, Maria M. Mangos, Anna-Lisa Tedeschi, Nicolay Ferrari
Rok vydání:	2006
Předmět:	Time Factors Biology General Biochemistry Genetics and Molecular Biology Inhibitory Concentration 50 Structure-Activity Relationship chemistry.chemical_compound Drug Stability History and Philosophy of Science Humans Structure–activity relationship Gene silencing Potency Gene Silencing RNA Small Interfering Luciferases Gene knockdown Nuclease Arabinonucleotides Oligonucleotide General Neuroscience RNA Oligonucleotides Antisense Thionucleotides Molecular biology Biochemistry chemistry biology.protein DNA HeLa Cells
Zdroj:	Annals of the New York Academy of Sciences. 1082:91-102
ISSN:	0077-8923
DOI:	10.1196/annals.1348.032
Popis:	Antisense oligonucleotides (AON) are being developed for a wide array of therapeutic applications. Significant improvements in their serum stability, target affinity, and safety profile have been achieved with the development of chemically modified oligonucleotides. Here, we compared 2'-deoxy-2'-fluoro-beta-D-arabinonucleic acid (FANA)-containing AONs with phosphorothioate oligodeoxynucleotides (PS-DNA), 2'-O-methyl-RNA/DNA chimeras and short interfering RNAs (siRNA) with respect to their target knockdown efficacy, duration of action and resistance to nuclease degradation. Results show that two different configurations of FANA/DNA chimeras (altimers and gapmers) were found to have potent antisense activity. Specific target inhibition was observed with both FANA configurations with an estimated EC50 value comparable to that of an siRNA but 20-to 100-fold lower than the other commonly used AONs. Moreover, the FANA/DNA chimeras showed increased serum stability that was correlated with sustained antisense activity for up to 4 days. Taken together, these results indicate that chimeric FANA/DNA AONs are promising new tools for therapeutic gene silencing when increased potency and duration of action are required.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ef69b05e3b321f7cda6c2e3c69685a https://doi.org/10.1196/annals.1348.032 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.